Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RBR-2x86dcRecruiting
Open-label trial in schizophrenia (2 arms), sponsored by Federal University of São Paulo. Primary endpoint: Hospitalization rate associated with psychotic relapses. Started Aug 2015; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on RBR-2x86dc.